Introduction: Previous epidemiology analysis of tumor registries established that gastroenteropancreatic neuroendocrine neoplasms (GEP-NETs) were both more prevalent, and more malignant, than previously recognized.
Aim(s): To define how the epidemiology (incidence, ethnicity, gender, survival) of GEP-NETs has evolved in the US to determine priorities for current research.
Materials and methods: We interrogated the most recent release (1973 to 2007) of the Surveillance, Epidemiology and End Results (SEER) database using the SEERStat analysis tool, examining organ- and cell-specific neuroendocrine tumors localized to the gastrointestinal tract and pancreas. Specific foci were gender/ethnicity; outcomes were incidence and survival.
Conference: 8th Annual ENETS Conference (2011)
Presenting Author: Dr. Mark Kidd
To read results and conclusion, please login ...
Further abstracts you may be interested in